Replies to post #425239 on Anavex Life Sciences Corp (AVXL)

[poguemahone]

Here is a preview of what our esteemed DM will say at the CC (which is exactly what he has said for the past 8 years):

We are working towards addressing CNS conditions with high unmet needs.

Our approach is to target the Sigmar 1 receptor, which is an upstream approach to return neurons to cellular homeostasis (like the firetruck at the firehouse that puts out the fire).

We have 5 years of cash on hand to run our trials, and even more if we want because we have an agreement with LPC to get more cash for issuing more shares.

We are VERY EXCITED about our future.

We are looking forward to sharing more information and results in the “near future”, which really means you might not be alive by the time we figure this all out.

We are working on an undisclosed rare CNS condition, and I will continue to keep this condition undisclosed because I myself have no idea what this condition is.

Have J missed anything that I haven’t already heard 20 times from Doctor BS?